Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_01218
Species: Homo sapiens
Position : chr5:172131000-172132000
Year: 2018
Title: Genomic dissection of enhancers uncovers principles of combinatorial regulation and cell type-specific wiring of enhancer-promoter contacts
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: osteosarcoma
PMID:  29385519
MONDO: MONDO:0005087
Tissue: Bone
Tissue Ontology ID: UBERON:0001474
Cell Source: U2OS
CVCL ID: CVCL_0042
Cell Type: osteosarcoma cell
Cell Ontology ID: CL:0000062
Experiment Type: Enhancer activity assay, Chromatin interaction assay
High Throughput Method: ChIP-seq, Hi-C
Low Throughput Method: qRT-PCR, and ChIP-qPCR
About Target Gene
Target gene : DUSP1
About TF
TF name : NR3C1
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
NR3C1 AndrogenReceptor netpath 167
NR3C1 AP-1 transcription factor network pid 71
NR3C1 BMAL1:CLOCK,NPAS2 activates circadian gene expression reactome 42
NR3C1 Cellular roles of Anthrax toxin pid 25
NR3C1 FOXA2 and FOXA3 transcription factor networks pid 45
NR3C1 Glucocorticoid receptor regulatory network pid 85
NR3C1 IL2 netpath 81
NR3C1 Nuclear Receptor transcription pathway reactome 51
NR3C1 PTK6 Expression reactome 5
NR3C1 Regulation of Androgen receptor activity pid 54
NR3C1 Regulation of nuclear SMAD2/3 signaling pid 82
NR3C1 Signaling events mediated by HDAC Class II pid 58
NR3C1 Neuroactive ligand-receptor interaction kegg 272
NR3C1 Hs_Endoderm_Differentiation_WP2853_88152 wikipathways 62
NR3C1 Hs_Serotonin_Receptor_4-6-7_and_NR3C_Signaling_WP734_74438 wikipathways 15
NR3C1 Hs_White_fat_cell_differentiation_WP3946_90940 wikipathways 30
NR3C1 Hs_Transcription_factor_regulation_in_adipogenesis_WP3599_88581 wikipathways 9
NR3C1 Hs_Sudden_Infant_Death_Syndrome_(SIDS)_Susceptibility_Pathways_WP706_86078 wikipathways 33
Enhancer Associated Network
Overlapping Enhancers (hg19) 1 found
Enhancer ID Position Tissue Cell Disease
E_01219 chr5:172131000-172132000 Lung lung adenocarcinoma cell lung adenocarcinoma
Expression of Target Genes for the Enhancer